Skip to main content
Premium Trial:

Request an Annual Quote

Singulex Closes $50M Debt Facility

NEW YORK (GenomeWeb) – Immunodiagnostic firm Singulex said today that it closed a $50 million senior secured debt facility with Perceptive Advisors. The firm plans to use the financing to continue to develop its single-molecule counting technology that detects disease-associated biomarkers.

Cantor Fitzgerald acted as exclusive financial advisor and sole placement agent to Singulex.

"The investment will help fuel our continued growth and innovation pipeline, including greater access of our Single Molecule Counting technology via our Sgx Clarity system and point-of-care platform," Singulex CEO and President Guido Baechler said in a statement.

Earlier this month, the Alameda, California-based firm received the CE mark in Europe for its Clarity system and said it planned to pursue the CE mark for its cardiac troponin I assay. In addition, it plans to submit data to the US Food and Drug Administration for clearance in 2018.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.